Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
10/1999
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054329A1 Novel 2-heterocyclically substituted dihydropyrimidines
10/28/1999CA2328876A1 Novel 2-heterocyclically substituted dihydropyrimidines
10/27/1999CN1233243A Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
10/27/1999CN1232824A Process for production of cyanuric chloride mouldings
10/27/1999CN1045955C Quinoline derivative and its producing process and its application and pharmaceutical composition containing the same derivative
10/26/1999US5973167 Sulfonamide group, ether containing acid
10/21/1999WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999WO1999052907A1 Azabicyclic 5ht1 receptor ligands
10/21/1999DE19817262A1 New dihydropyrimidine derivatives and their corresponding mesomers useful in treatment of hepatitis
10/21/1999CA2327782A1 Azabicyclic 5ht1 receptor ligands
10/20/1999EP0949920A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
10/20/1999EP0832078B1 N-hydroxyureas as antiinflammatory agents
10/20/1999CN1232025A Pyrrolidine and piperidine derivatives
10/20/1999CN1045770C Method for preparation of 1-biphenylmethyl imidazole derivs.
10/19/1999US5969156 Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
10/19/1999US5968953 For side effect reduction
10/14/1999WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999WO1999051578A1 Biocidal benzylbiphenyl derivatives
10/14/1999CA2326522A1 Pyrrolo¬1,2-a|pyrazine spla2 inhibitor
10/14/1999CA2326159A1 Biocidal benzylbiphenyl derivatives
10/13/1999EP0949252A1 Process for the production of shaped bodies of cyanuric chloride
10/13/1999EP0948509A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
10/13/1999EP0948497A2 Substituted pyrimidine compounds and their use
10/13/1999EP0646116B1 Process and intermediates for bis-aza-bicyclic anxiolytic agents
10/13/1999EP0574457B1 Antiviral nucleoside combination
10/13/1999EP0540609B1 Cephalosporins and homologues, preparations and pharmaceutical compositions
10/13/1999CN1231661A Aralkyl and aralkylidene heterocyclic lactams and imides
10/13/1999CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/12/1999US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/07/1999WO1999050267A1 Process for producing isooxazolidinedione compound
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/06/1999EP0946511A1 Novel compounds with analgesic effect
10/06/1999CN1230542A Sidechain-bearing taxanes
10/06/1999CN1230407A Method and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
10/06/1999CN1045435C Naphthalene derivative, preparation thereof and middle agent syntherised of same
10/05/1999US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors
09/1999
09/30/1999WO1999038877A3 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
09/29/1999EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
09/29/1999CN1230187A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/29/1999CN1230185A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/23/1999WO1999047525A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
09/23/1999WO1999047521A1 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
09/23/1999WO1999039694A3 Compositions containing organic compounds
09/23/1999CA2324270A1 Hypnotic .beta.-carboline derivatives, process for their preparation and their use as medicinal products
09/22/1999CN1229080A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
09/22/1999CN1229079A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
09/22/1999CN1229078A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
09/21/1999US5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
09/16/1999WO1999046240A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
09/16/1999CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases)
09/16/1999CA2323472A1 Modulators of protein tyrosine phosphatases
09/16/1999CA2322873A1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
09/15/1999CN1045087C Preparation of imidazopyridine derivative
09/14/1999US5952495 Preparation of 14-hydroxynormorphinones from normorphinones
09/14/1999US5952369 Pyrrolidinyl hydroxamic acid compounds and their production process
09/14/1999US5952362 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxyphenyl, and aminophenyl alkylsulfonamides and ureas and their use
09/10/1999WO1999044991A1 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
09/08/1999EP0940394A1 Chemical process
09/08/1999EP0589874B1 Use of (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid for the preparation of a longlasting antidiabetic medicament
09/07/1999US5948788 Normorphine and normorphinone derivatives
09/07/1999CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present
09/02/1999WO1999043285A2 Sulphonamide derivatives
09/02/1999CA2322139A1 Sulphonamide derivatives
09/01/1999EP0939135A1 Substantially pure hetero-bicyclic alcohol enantiomers
09/01/1999EP0938481A1 Processes and intermediates for the preparation of oxazoline derivatives
09/01/1999CN1227487A Pharmaceutical compositions containing mesembrine and related compounds
08/1999
08/31/1999US5945440 Indolocarbazole imides and the use thereof
08/25/1999EP0937708A2 sulphonamide derivatives
08/25/1999EP0937458A2 Pyrrolidine and piperidine derivatives
08/24/1999US5942630 Process for the production of enantiomerically-pure azetidine-2-carboxylic acid
08/24/1999US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia
08/19/1999WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/17/1999US5939555 Polymorphs B and C of 1- 2,4-dichloro-β- (7-chlorobenzo b!thien-3-yl)methoxy!phenethyl!imidazole mononitrate
08/17/1999US5939433 Quinuclidine derivatives
08/17/1999CA2195622C Process for preparing trans-piperidine-2,5-dicarboxylates
08/12/1999WO1999039694A2 Compositions containing organic compounds
08/11/1999EP0934311A2 New heterocyclylmethyl-substituted pyrazol derivates
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/10/1999CA2260698A1 Pyrrolidine and piperidine derivatives
08/05/1999WO1999038877A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
08/05/1999WO1999022722A3 Use of macrolides for the treatment of cancer and macular degeneration
08/05/1999DE19903870A1 New 3,3,5,5-tetraalkyl-2-oxo-1,4-piperazine derivatives, used as light, heat and oxygen stabilizers e.g. in photographic and reprographic materials and in paper
08/05/1999CA2318278A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/04/1999EP0932402A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
08/04/1999EP0628038B1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO [b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION
08/04/1999CN1044473C Tropone-substituted phenyloxazolidinone antibacterial agents
08/03/1999US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
08/03/1999CA2005986C Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
08/02/1999CA2260568A1 Oxopiperazinyl derivatives and light stabilized compositions
07/1999
07/29/1999WO1999008500A3 New crystalline form of omeprazole
07/29/1999DE19816026C1 Production of cyanuric chloride molding, e.g. dust-free rodlets or flakes, without sublimation
07/28/1999EP0931786A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
07/28/1999CN1223859A Process for preparation of pharmaceutical composition
07/28/1999CN1044367C (S)-alpha-phenyl-2-pyridine-ethylamine, its preparing method and composition contg. same
07/27/1999CA2016504C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
07/22/1999WO1999036396A1 Triazepinones, process for their preparation and their therapeutic application
07/21/1999EP0929528A1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/21/1999CN1044242C Heterocyclic-cyclic amine derivatives
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 105